The Motley Fool

TSX:HEXO (Hexo Corp.)

$0.95 $0.00 (0.00) Tuesday, August 11, 2020 at 4:00:00 p.m. Eastern Daylight Time

About

Last updated Aug 11, 2020, 04:00:00pm EDT
Current Price $0.95
Today's Change $0.00 (0%)
Close Price $0.95
Open Price $0.95
Bid $0.93
Ask $0.95
Day Range $0.92 - $0.96
Year Range $0.50 - $6.54
Volume 1,294,886
Average Volume 3,471,082
Market Cap $440,459,741.00
EPS (ttm) $-1.59

Related Articles

HEXO (TSX:HEXO) Abruptly Changes Auditors: Should Investors Raise Eyebrows?

Auditors do get changed over time, and it’s encouraged, but investors may raise questions when auditors abruptly resign, as in the HEXO's case. More »

Top Pot Stocks for the Next Generation of Cannabis Products

Hexo Corp (TSX:HEXO)(NYSE:HEXO) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are your top choices for the cannabis future. More »

Top Cannabis Stocks for 2020

Why you should prefer Hexo Corp (TSX:HEXO)(NYSE:HEXO) and Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) in the year to come. More »

If You’d Invested $100,000 in Hexo (TSX:HEXO) Stock in April 2019, You’d Be Poorer Now

Hexo stock is a classic case of the last year’s cannabis crash. It has lost 81.58% of its value since April 2019. More »

Top Canadian Stocks for February 2020

We asked our freelance writers to share their top stock picks for the month. More »

Why Is Hexo (TSX:HEXO) Stock Down 22% in 2020?

Hexo stock continues to fall in 2020. Will it move lower or is it poised for a comeback? More »

TFSA Investor Wish List: 2 Ways to Make $10,000

Want to grow your TFSA quickly? Use this simple trick, then invest in high-growth companies like Hexo Corp (TSX:HEXO)(NYSE:HEXO). More »

Is Hexo (TSX:HEXO) Stock a Buy at its Current Price?

Do you need to consider Hexo stock after its 80% decline since April 2019? More »

This Pot Stock Is Perfect for a TFSA

Hexo Corp (TSX:HEXO)(NYSE:HEXO) stock could provide major gains in 2020, all of which would be tax free with a TFSA. More »

Are These 2 Top Canadian Cannabis Stocks a Buy?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and a rival in the legal cannabis space could be strong plays for contrasting strategies. More »